Cargando...
High-throughput flow cytometry (HTFC) drug combination discovery with novel synergy analysis software, SynScreen
Classical therapeutic regimens are subject to toxicity, low efficacy, and/or the development of drug resistance. Thus, the discovery of synergistic drug combinations would permit treatment with lower, tolerable dosages of each agent and restored sensitivity. We describe the development and use of th...
Guardado en:
| Publicado en: | SLAS Discov |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6363001/ https://ncbi.nlm.nih.gov/pubmed/29842834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2472555218775913 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|